IBC-Ab002: Immune System Activation for Cognitive Improvement in Alzheimer Disease.

Published Date: 09 Jul 2023

IBC-Ab002, a promising anti-PD-L1 monoclonal antibody to enhance cognition in patients with Alzheimer disease, was discussed by Robert Glanzman, MD, the chief medical officer at ImmunoBrain Checkpoint.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

2.

Glioblastoma treatment breakthrough shows promise

3.

A computer-aided diagnostic system for improved detection of breast cancer.

4.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

5.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot